HGH1 Promotes Breast Cancer Progression Through the PI3K/AKT/NF-κB Signaling Pathway: Potential Role for Prognosis and Targeted Therapy
HGH1 promotes the growth of BC cells by activating the PI3K/AKT/NF-κB signaling pathway. HGH1 may become a new indicator for evaluating the poor prognosis of BC patients and serve as a potential diagnostic biomarker and therapeutic target for breast cancer.
Authors
- Nanlin Li (ORCID: https://orcid.org/0000-0002-8762-9439)
- Dongdong Xu (ORCID: https://orcid.org/0009-0008-3411-7924)
- Dan-Chen Tie
- Chenxi Liu (ORCID: https://orcid.org/0000-0001-5888-4097)
- Wenyu Hu (ORCID: https://orcid.org/0000-0001-6508-897X)
- Daowen Si
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Xijing Hospital (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/bctt.s505492
- Citations
- 2
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 2.64